文献速递肝病胰腺与胆道疾病

美国人群中非恶性肝脏与胰腺疾病的负担:发生率与趋势

Burden of Nonmalignant Liver and Pancreatic Diseases in the United States Population: Rates and Trends.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-03-25

该研究利用美国全国急诊样本、住院样本、生命统计死亡数据及医保索赔数据库,估计过去十年非恶性肝脏与胰腺疾病的患病率、医疗使用和死亡率。肝病医疗使用和死亡率上升,逆转此前下降趋势;胰腺炎医疗使用率趋稳或下降,死亡率至2019年下降后至2021年上升。

要点

  • 肝病医疗使用和死亡率上升,逆转此前下降趋势。

核心结论

  • 美国非恶性肝脏与胰腺疾病负担重大,肝病死亡率在逆转此前下降趋势后上升尤其令人担忧。
  • 持续监测肝病和胰腺炎患病率可能更好地为研究项目提供信息。

研究设计与样本

  • 使用全国急诊样本、全国住院样本、美国生命统计多死因数据、Optum Clinformatics Data Mart及医疗保险和医疗补助服务中心的Medicare 5%样本和Medicaid文件,估计基于索赔的患病率、医疗使用和死亡率。
  • 研究过去十年美国非恶性肝脏与胰腺疾病的负担率和趋势。

主要发现

  • 两种疾病中,男性和美洲印第安人/阿拉斯加原住民的死亡和医疗使用负担更大。
  • 研究期间,肝病诊断的医疗使用和死亡率上升,逆转此前下降趋势。
  • 胰腺炎医疗使用率近年趋稳或下降,死亡率至2019年下降后至2021年上升。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonmalignant liver and pancreatic diseases are common in the United States and lead to significant morbidity, mortality, and health care utilization. We used national survey and claims databases to investigate rates and trends in the liver and pancreatic disease burden over the past decade in the United States. The Nationwide Emergency Department Sample, National Inpatient Sample, Vital Statistics of the United States: Multiple Cause-of-Death Data, Optum Clinformatics Data Mart, and Centers for Medicare and Medicaid Services Medicare 5% Sample and Medicaid files were used to estimate claims-based prevalence, medical care use, and mortality with an all-listed liver or pancreatic disease diagnosis. In the US population, liver disease contributed to 2.7 million emergency department visits, 2 million hospital stays, and 134,000 deaths in 2021. Pancreatitis was a less common but still significant cause of health care use contributing to 733,000 emergency department visits, 552,000 hospital stays, and 9000 deaths in 2021. For both conditions, male and American Indian/Alaska Native persons had a greater mortality and medical care use burden. During the study period, both medical care use and mortality rates with a liver disease diagnosis rose, concerningly reversing previously declining trends. For pancreatitis, medical care use rates stabilized or declined during recent years and the mortality rate declined through 2019 and then rose through 2021. The burden of nonmalignant liver and pancreatic diseases in the United States is substantial. The rise in liver disease mortality rates following the reversal of a previous downward trend is particularly concerning. Hence ongoing surveillance of liver disease and pancreatitis prevalence may better inform research programs.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Unalp-Arida A, Ruhl CE. Burden of Nonmalignant Liver and Pancreatic Diseases in the United States Population: Rates and Trends. Clin Gastroenterol Hepatol. 2025. PMID: 40147498. doi:10.1016/j.cgh.2025.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。